Connect with us

Hi, what are you looking for?


Brand Name Breakouts Amid A Mixed Market

The stock market remains in an uptrend after modest gains for the week that occurred amid signs that the economy is slowing down while inflation is cooling. It was a period marked by large intraday moves however, as investor’s digested news that Fed officials are anticipating a mild recession later this year. Also, data last week showed that while inflation is slowing, it remains at a highly elevated level which may lead to more rate hikes.


Fed rate hikes in the face of a possible recession is not a great backdrop for the markets and last week’s underperformance in the Technology sector underscored investor’s concern. These high growth stocks are particularly vulnerable to higher rates and concerns of a slowing economy.

At this time, investing in companies that are growing and that also fare well despite a potential slowdown in the economy would be a great way to participate in the current uptrend. Focusing on stocks that are also breaking out of a sound base would be ideal, as this chart pattern often precedes further upside price action. Below is a prime example of a recession proof company that broke out of a base last month amid an improved growth outlook.


Subscribers to my MEM Edge Report are quite familiar with McDonald’s (MCD) as we added the stock to our select list of Suggested Holdings in late March after its base breakout on above average volume. MCD’s affordable menu coupled with their operating margins improving more than Microsoft and other tech companies, had Wall Street raising their growth outlook for the company into year end. Of note, McDonald’s opened almost 600 new locations during the great recession of 2008 while most restaurants retreated. The stock is in a confirmed uptrend with further upside potential.

Below is Merck (MRK) which broke out of a 3-month base last week amid news that the FDA has accepted for review their Keytruda based therapy for advanced GI cancer. This news adds to the company’s exceptionally deep drug pipeline that has analysts calling for above average earnings growth over the next five years. The 2.5% yielder is also trading at 15 times trailing 4 quarter earnings which is below the average P/E for stocks in the S&P 500.


Healthcare stocks also outperformed during 2008 and while we’re not calling for a recession that will be anywhere close to what took place back then, precedence tells us that innovative drug companies can fare well despite a difficult economic backdrop. Merck (MRK) has positive momentum with its RSI and MACD above 50 and headed higher and last week’s base breakout puts the stock in a position to trade higher.

While Technology stocks have underperformed over the past two weeks, the sector remains in an uptrend with select areas posting solid gains. My MEM Edge Report has several high quality Technology stocks on the Suggested Holdings List that have been outpacing the broader markets and are poised to continue to do so.  We’ll stay with these stocks as long as they remain in an uptrend.

If you’d like immediate access to my Suggested Holdings List as well as be kept on top of our detailed market and sector rotation analysis during these choppy times, use this link for a 4-week trial of my twice weekly MEM Edge Report at a nominal fee.


Mary Ellen McGonagle, MEM Investment Research

You May Also Like


The head of the International Monetary Fund has warned of increased risks to the stability of the financial system after weeks of banking sector...


After taking a breather in the week before this one, the Indian equity markets resumed their up move. The headline index continued with its...


It was supposed to be a debacle. As the Second World War drew to a close, the nation’s leading economists feared that, once the...


Small businesses are bringing forward their finance applications in order to beat expected further interest rate rises, according to new research. Four-in-ten (44%) SME...

Dislaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2023 | All Rights Reserved